|
End-of-day quote
Egyptian Exchange
|
||
| - EGP | - |
|
| 21/05 | The Arab Drug Company Reports Earnings Results for the Nine Months Ended March 31, 2026 | CI |
| 30/04 | Arab Drug Company 9-month net profit EGP 196.4 million | RE |
| Market Cap | 2.89B 57.42M 49.48M 46.39M 42.35M 79.78M 5.49B 80.04M 550M 215M 2.77B 216M 211M 9.19B | P/E 2024 |
5.46x | P/E 2025 | 6.08x |
|---|---|---|---|---|---|
| Enterprise Value | 3.32B 66.04M 56.9M 53.35M 48.7M 91.75M 6.31B 92.04M 633M 247M 3.19B 248M 243M 10.56B | EV / Sales 2024 |
0.98x | EV / Sales 2025 | 1.47x |
| Free-Float |
18.09% | Yield 2024 |
10.4% | Yield 2025 | 4.14% |
| Manager | Title | Age | Since |
|---|---|---|---|
Tariq Ali
DFI | Director of Finance/CFO | - | - |
Yosef Omr Amer
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | - | |
| Director/Board Member | - | - | |
| Director/Board Member | - | 30/09/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.13% | -6.44% | +60.34% | +112.06% | 1,047B | |
| +0.85% | -0.81% | +51.29% | +63.13% | 646B | |
| -1.03% | -3.58% | +21.43% | +73.10% | 451B | |
| -1.46% | -4.50% | +37.80% | +37.41% | 355B | |
| -0.72% | -2.89% | +22.32% | +36.62% | 291B | |
| -1.19% | -2.21% | +1.53% | +10.79% | 252B | |
| -1.05% | -1.57% | +50.30% | +66.55% | 234B | |
| +0.08% | -1.78% | -17.64% | -54.36% | 203B | |
| -2.14% | -0.30% | +28.95% | +86.27% | 181B | |
| Average | -0.75% | -2.62% | +28.48% | +47.95% | 406.59B | |
| Weighted average by Cap. | -0.46% | -3.43% | +38.17% | +65.00% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 786M 15.63M 13.47M 12.63M 11.53M 21.72M 1.49B 21.79M 150M 58.46M 754M 58.69M 57.41M 2.5B | 1.12B 22.25M 19.17M 17.98M 16.41M 30.92M 2.13B 31.01M 213M 83.22M 1.07B 83.54M 81.72M 3.56B |
| Net income | 103M 2.05M 1.76M 1.65M 1.51M 2.84M 196M 2.85M 19.61M 7.65M 98.72M 7.68M 7.52M 327M | 228M 4.53M 3.91M 3.66M 3.34M 6.3M 433M 6.32M 43.46M 16.96M 219M 17.02M 16.65M 725M |
| Net Debt | 284M 5.66M 4.88M 4.57M 4.17M 7.86M 541M 7.89M 54.24M 21.16M 273M 21.25M 20.78M 905M | 433M 8.61M 7.42M 6.96M 6.35M 11.97M 823M 12.01M 82.57M 32.22M 416M 32.34M 31.64M 1.38B |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
